We very rarely delete comments (as per the policy). But many get shunted to spam, far more than we can examine (thousands a month, really).
It would be easy to construe Judge Vinson’s decision allowing the challenge to health care reform in Florida to proceed as bolstering the claim that
Matt Yglesias cited Aaron’s post and figures on mortality after age 65 and commented, Strong evidence of systematic underperformance in the American system. And yet since
David Dranove has just published a post worth reading on The Health Care Blog. It makes some of the same points I’ve been making about
As a prelude to Aaron’s upcoming series on health care quality (begins Monday), I want to come back to something I wrote in August about descriptive
I’ve found, read, and reviewed six papers in my Medicaid-IV series. These are ones that met my criteria for sound methodology for estimating the causal effect
The latest edition of Health Wonk Review is hosted by Jason Shafrin at Healthcare Economist. Aaron’s intro post to his health care cost series gets
When we discuss life expectancy, inevitably someone tries to explain away our sup-optimal performance by pointing to our demographics, specifically with respect to race. “We’re
Some days just warrant a lot of posts. This is one of them. I’ll keep this one brief. I rarely declare things “must reads,” but
Medicaid is not bad for health. I’ll come back to that point later today. For the moment, see how it matches up against private plans
[A] ban on valuing life extension presents its own ethical dilemmas. Taken literally, it means that spending resources to extend by a month the life
Life expectancy as a metric is so controversial that I felt it deserved further exploration. People don’t like it because they think lots of things
the health services research blog
Work posted here under copyright © of the authors • Details on the Site Policies page
